HAVAH Therapeutics is a San Francisco-based women’s hormonal health biopharmaceutical company. We develop innovative, proprietary hormonal therapies that aim to improve quality of life for women across the world. We bring together a world-class team passionate about helping women live lives free from the suffering caused by breast pain, debilitating menopausal symptoms and breast cancer. HAVAH Therapeutics lead drug candidate T+Ai™ is currently undergoing clinical trials into the reduction of mammographic breast density and breast cancer prevention.